Combinatorial PCR approach to homology-based cloning: Cloning and expression of mouse and human GM3-synthase

Dmitri Kapitonov, Erhard Bieberich, Robert K Yu

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

GM3-synthase, also known as sialyltransferase I (ST-I), catalyzes the transfer of a sialic acid residue from CMP-sialic acid onto lactosylceramide to form ganglioside GM3. In order to clone this enzyme, as well as other sialyltransferases, we developed an approach that we termed combinatorial PCR. In this approach, degenerate primers were designed on the basis of conserved sequence motifs of the ST3 family of sialyltransferases (STs). The nucleotide sequence of the primers was varied to cover all amino acid variations occurring in each motif. In addition, in some primers the sequence was varied to cover possible homologous substitutions that are absent in the available motifs. A panel of cDNA from 12 mouse and 8 human tissues was used to enable cloning of tissue- and stage-specific sialyltransferases. Using this approach, the fragments of 11 new putative sialyltransferases were isolated and sequenced so far. Analysis of the expression pattern of a particular sialyltransferase across the panel of cDNA from the different tissues provided information about the tissue specificity of ST expression. We chose two new ubiquitously expressed human and mouse STs to clone full-length copies and to assay for GM3-synthase activity. One of the STs, which exhibited the highest homology to ST3 Gal III, showed activity toward lactosylceramide (LacCer) and was termed ST3 Gal V according to the suggested nomenclature. The other ubiquitously expressed sialyltransferase was termed ST3Gal VI. All isolated sialyltransferases were screened for alternatively spliced forms (ASF). Such forms were found for both human ST3Gal V and ST3Gal VI in human fetal brain cDNA library. The detailed cloning strategy, functional assay, and full length cDNA and protein sequences of GM3 synthase (ST3Gal V, or ST-I) are presented.

Original languageEnglish (US)
Pages (from-to)337-350
Number of pages14
JournalGlycoconjugate Journal
Volume16
Issue number7
DOIs
StatePublished - Nov 25 1999

Fingerprint

Sialyltransferases
Cloning
Organism Cloning
Polymerase Chain Reaction
beta-galactoside alpha-2,3-sialyltransferase
Tissue
Complementary DNA
haematoside synthetase
Assays
Cytidine Monophosphate N-Acetylneuraminic Acid
Clone Cells
G(M3) Ganglioside
Organ Specificity
Conserved Sequence
N-Acetylneuraminic Acid
Terminology
Gene Library
Brain

Keywords

  • GM3-synthase
  • Molecular cloning of glycosyltransferases
  • PCR
  • Sialyltransferase
  • cDNA

ASJC Scopus subject areas

  • Biochemistry

Cite this

Combinatorial PCR approach to homology-based cloning : Cloning and expression of mouse and human GM3-synthase. / Kapitonov, Dmitri; Bieberich, Erhard; Yu, Robert K.

In: Glycoconjugate Journal, Vol. 16, No. 7, 25.11.1999, p. 337-350.

Research output: Contribution to journalArticle

@article{762a5127c252466cbeaf380e9cb53fed,
title = "Combinatorial PCR approach to homology-based cloning: Cloning and expression of mouse and human GM3-synthase",
abstract = "GM3-synthase, also known as sialyltransferase I (ST-I), catalyzes the transfer of a sialic acid residue from CMP-sialic acid onto lactosylceramide to form ganglioside GM3. In order to clone this enzyme, as well as other sialyltransferases, we developed an approach that we termed combinatorial PCR. In this approach, degenerate primers were designed on the basis of conserved sequence motifs of the ST3 family of sialyltransferases (STs). The nucleotide sequence of the primers was varied to cover all amino acid variations occurring in each motif. In addition, in some primers the sequence was varied to cover possible homologous substitutions that are absent in the available motifs. A panel of cDNA from 12 mouse and 8 human tissues was used to enable cloning of tissue- and stage-specific sialyltransferases. Using this approach, the fragments of 11 new putative sialyltransferases were isolated and sequenced so far. Analysis of the expression pattern of a particular sialyltransferase across the panel of cDNA from the different tissues provided information about the tissue specificity of ST expression. We chose two new ubiquitously expressed human and mouse STs to clone full-length copies and to assay for GM3-synthase activity. One of the STs, which exhibited the highest homology to ST3 Gal III, showed activity toward lactosylceramide (LacCer) and was termed ST3 Gal V according to the suggested nomenclature. The other ubiquitously expressed sialyltransferase was termed ST3Gal VI. All isolated sialyltransferases were screened for alternatively spliced forms (ASF). Such forms were found for both human ST3Gal V and ST3Gal VI in human fetal brain cDNA library. The detailed cloning strategy, functional assay, and full length cDNA and protein sequences of GM3 synthase (ST3Gal V, or ST-I) are presented.",
keywords = "GM3-synthase, Molecular cloning of glycosyltransferases, PCR, Sialyltransferase, cDNA",
author = "Dmitri Kapitonov and Erhard Bieberich and Yu, {Robert K}",
year = "1999",
month = "11",
day = "25",
doi = "10.1023/A:1007091926413",
language = "English (US)",
volume = "16",
pages = "337--350",
journal = "Glycoconjugate Journal",
issn = "0282-0080",
publisher = "Springer Netherlands",
number = "7",

}

TY - JOUR

T1 - Combinatorial PCR approach to homology-based cloning

T2 - Cloning and expression of mouse and human GM3-synthase

AU - Kapitonov, Dmitri

AU - Bieberich, Erhard

AU - Yu, Robert K

PY - 1999/11/25

Y1 - 1999/11/25

N2 - GM3-synthase, also known as sialyltransferase I (ST-I), catalyzes the transfer of a sialic acid residue from CMP-sialic acid onto lactosylceramide to form ganglioside GM3. In order to clone this enzyme, as well as other sialyltransferases, we developed an approach that we termed combinatorial PCR. In this approach, degenerate primers were designed on the basis of conserved sequence motifs of the ST3 family of sialyltransferases (STs). The nucleotide sequence of the primers was varied to cover all amino acid variations occurring in each motif. In addition, in some primers the sequence was varied to cover possible homologous substitutions that are absent in the available motifs. A panel of cDNA from 12 mouse and 8 human tissues was used to enable cloning of tissue- and stage-specific sialyltransferases. Using this approach, the fragments of 11 new putative sialyltransferases were isolated and sequenced so far. Analysis of the expression pattern of a particular sialyltransferase across the panel of cDNA from the different tissues provided information about the tissue specificity of ST expression. We chose two new ubiquitously expressed human and mouse STs to clone full-length copies and to assay for GM3-synthase activity. One of the STs, which exhibited the highest homology to ST3 Gal III, showed activity toward lactosylceramide (LacCer) and was termed ST3 Gal V according to the suggested nomenclature. The other ubiquitously expressed sialyltransferase was termed ST3Gal VI. All isolated sialyltransferases were screened for alternatively spliced forms (ASF). Such forms were found for both human ST3Gal V and ST3Gal VI in human fetal brain cDNA library. The detailed cloning strategy, functional assay, and full length cDNA and protein sequences of GM3 synthase (ST3Gal V, or ST-I) are presented.

AB - GM3-synthase, also known as sialyltransferase I (ST-I), catalyzes the transfer of a sialic acid residue from CMP-sialic acid onto lactosylceramide to form ganglioside GM3. In order to clone this enzyme, as well as other sialyltransferases, we developed an approach that we termed combinatorial PCR. In this approach, degenerate primers were designed on the basis of conserved sequence motifs of the ST3 family of sialyltransferases (STs). The nucleotide sequence of the primers was varied to cover all amino acid variations occurring in each motif. In addition, in some primers the sequence was varied to cover possible homologous substitutions that are absent in the available motifs. A panel of cDNA from 12 mouse and 8 human tissues was used to enable cloning of tissue- and stage-specific sialyltransferases. Using this approach, the fragments of 11 new putative sialyltransferases were isolated and sequenced so far. Analysis of the expression pattern of a particular sialyltransferase across the panel of cDNA from the different tissues provided information about the tissue specificity of ST expression. We chose two new ubiquitously expressed human and mouse STs to clone full-length copies and to assay for GM3-synthase activity. One of the STs, which exhibited the highest homology to ST3 Gal III, showed activity toward lactosylceramide (LacCer) and was termed ST3 Gal V according to the suggested nomenclature. The other ubiquitously expressed sialyltransferase was termed ST3Gal VI. All isolated sialyltransferases were screened for alternatively spliced forms (ASF). Such forms were found for both human ST3Gal V and ST3Gal VI in human fetal brain cDNA library. The detailed cloning strategy, functional assay, and full length cDNA and protein sequences of GM3 synthase (ST3Gal V, or ST-I) are presented.

KW - GM3-synthase

KW - Molecular cloning of glycosyltransferases

KW - PCR

KW - Sialyltransferase

KW - cDNA

UR - http://www.scopus.com/inward/record.url?scp=0000960815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0000960815&partnerID=8YFLogxK

U2 - 10.1023/A:1007091926413

DO - 10.1023/A:1007091926413

M3 - Article

C2 - 10619706

AN - SCOPUS:0000960815

VL - 16

SP - 337

EP - 350

JO - Glycoconjugate Journal

JF - Glycoconjugate Journal

SN - 0282-0080

IS - 7

ER -